Home » Ranbaxy May Divest 60 Percent in R&D Arm
Ranbaxy May Divest 60 Percent in R&D Arm
Pharma major Ranbaxy Laboratories is planning to divest 60 percent of its R&D arm, which it plans to hive off into a separate company, reports Economic Times.
My Iris
Upcoming Events
-
07May
-
14May
-
30May